|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.85 CNY | +0.11% |
|
+7.18% | +7.18% |
| Jan. 07 | Hengrui Pharmaceuticals Wins China Marketing Approval for Gastric Cancer Drug | MT |
| Jan. 07 | Jiangsu Hengrui Pharmaceuticals says unit got notice from NMPA for retlirafusp alfa injection | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 63.85 | 72.47 | 72.47 |
| Spread/Res. | +0.00% | -11.89% | -11.89% |
| Spread/Supp. | +3.32% | +13.21% | +13.21% |
| Support | 61.8 | 56.4 | 56.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 600276 Stock
- Charts Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Select your edition
All financial news and data tailored to specific country editions
